Practical Investing

Follow columnist Kathy Kristof as she shares lessons from her real-life investment portfolio.

April 4, 2018

Why I Paid a Premium for Costco

It isn’t just the shopping experience that has sold me on the stock. I also love how Costco runs its business.

See More On: Stocks & Bonds

March 8, 2018

What I Bought When Stocks Tanked

Our "Practical Investing" columnist happily seized the moment to buy two stocks that had been on her wish list for a long time: Costco and Boeing.

See More On: Stocks & Bonds | Tech Stocks

February 1, 2018

How My Portfolio Performed in 2017

The market ran so fast that the relatively conservative portfolio of Kiplinger's Practical Investor simply couldn't keep up.

See More On: Stocks & Bonds | Index Funds

January 8, 2018

For Value, GM Beats Tesla by a Mile

Tesla gets all the attention, but with actual profits, GM can afford to finance innovation.

See More On: Stocks & Bonds

December 6, 2017

How I can Afford Semi-Retirement at Age 56

When you've got a novel to write, but still have bills to pay, well-timed stock sales can help keep the balance.

See More On: Stocks & Bonds | Saving for Retirement

November 2, 2017

Why I Think Apple's Stock Is a Bargain

Though Apple is already largest holding in my portfolio, I'm sorely tempted to buy more.

See More On: Tech Stocks | Stocks & Bonds

September 22, 2017

Investors, Don't Let Current Events Spook You

It may seem like you’re facing the storm of the century every time you turn on the news, but the markets have survived far worse.

See More On: Stocks & Bonds | Economic Forecasts

August 1, 2017

I Add Two Bargains to My Portfolio

One pick, Lazard, is a global investment banking firm. Its reasonable share price provides a margin of safety.

See More On: Stocks & Bonds | Saving for Retirement

May 1, 2017

Is Intel's Buying Binge a Good Thing?

Intel’s purchase of Mobileye is its second mega-deal in the past two years, but Intel doesn’t have a stellar history when it comes to big acquisitions.

See More On: Stocks & Bonds | Tech Stocks

April 6, 2017

Can This Fallen Biotech Be Revived?

I've been sorely tempted to sell my Gilead shares. But now that they're cheaper, maybe I should buy more.

See More On: Stocks & Bonds | Tech Stocks

January 3, 2017

This Stumbling Biotech Stock Still Has a Lot of Promise

Gilead Sciences' robust product pipeline should turn things around.

See More On: Stocks & Bonds | Tech Stocks

December 6, 2016

My Portfolio's Uninvited Guests

A well-considered spin-off can increase the value of both parent and child by allowing each to focus on a narrower set of goals.

See More On: Stocks & Bonds

November 1, 2016

Why Is My Portfolio Lagging? Blame It on 2015

A portfolio without FANGs was doomed to have trouble last year.

See More On: Stocks & Bonds

October 4, 2016

Learning From My Misguided Attempt to Beat the Market

Selling quality stocks was just one of the mistakes.

See More On: Investor Psychology

September 7, 2016

How Doing Nothing Can Pay Off for Investors

For the three-month period during which I essentially ignored my investments, the Practical Investing portfolio rose 10%.

See More On: Stocks & Bonds | Investor Psychology

June 7, 2016

AV Homes: A Cheap Stock With Rich Potential

This small homebuilder's first-quarter results were impressive, with big gains in number of dwellings sold and other key measures.

See More On: Stocks & Bonds

May 26, 2016

Biotech Giant Gilead Sciences Goes on Sale

Gilead Sciences stock was selling for a mere 7 times estimated 2016 earnings when I snapped up 150 shares.

See More On: Stocks & Bonds | Tech Stocks

Show More Stories